Trump's Medicaid Deal: Too Good (or Bad) to Be True? The administration's latest attempt to tackle America's rising prescription drug costs has sparked both enthusiasm and skepticism among experts and advocates.
On Friday, the White House announced that all 50 states will join a program providing "most favored nation pricing" for select drugs within the Medicaid program.
This move, proponents claim, will bring down the net price of these medications to levels paid in other countries, yielding billions in savings.